| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AKARI THERAPEUTICS PLC | 46,622 | 328,000 | 0.08% | ||
| 2 | SYNERGY PHARMACEUTICALS DEL | 55,000 | 335,000 | 0.08% | ||
| 3 | ACORDA THERAPEUTICS INC | 20,000 | 376,000 | 0.09% | ||
| 4 | OPHTHOTECH CORP | 86,100 | 416,000 | 0.10% | Call | |
| 5 | VANDA PHARMACEUTICALS INC COM | 46,000 | 734,000 | 0.18% | ||
| 6 | MIRATI THERAPEUTICS INC COM | 172,184 | 818,000 | 0.20% | ||
| 7 | ARIAD PHARMACEUTICALS ORD (NMS) | 75,000 | 933,000 | 0.22% | ||
| 8 | VTV THERAPEUTICS INC | 200,000 | 966,000 | 0.23% | ||
| 9 | ACCELERON PHARMA INC | 40,000 | 1,021,000 | 0.25% | ||
| 10 | ALCOBRA LTD | 500,000 | 1,050,000 | 0.25% | ||
| 11 | RA PHARMACEUTICALS INC COM | 75,000 | 1,139,000 | 0.27% | ||
| 12 | INCYTE CORP | 13,000 | 1,304,000 | 0.31% | ||
| 13 | VERACYTE INC | 200,000 | 1,548,000 | 0.37% | ||
| 14 | RIGEL PHARMACEUTICAL INC | 700,000 | 1,666,000 | 0.40% | ||
| 15 | INOTEK PHARMACEUTICALS CORP | 300,000 | 1,830,000 | 0.44% | Call | |
| 16 | BLUEBIRD BIO INC COM | 30,000 | 1,851,000 | 0.45% | ||
| 17 | HORIZON PHARMA PLC | 129,100 | 2,089,000 | 0.50% | Call | |
| 18 | TESARO INCORPORATED | 17,000 | 2,286,000 | 0.55% | ||
| 19 | XENON PHARMACEUTICALS INC | 325,000 | 2,503,000 | 0.60% | ||
| 20 | MEDICINES CO | 75,000 | 2,546,000 | 0.61% | ||
| 21 | ZOGENIX INC | 225,000 | 2,734,000 | 0.66% | ||
| 22 | IRIDEX CORP | 200,000 | 2,812,000 | 0.68% | ||
| 23 | ACADIA PHARMACEUTICALS INC COM | 100,000 | 2,884,000 | 0.69% | ||
| 24 | ACLARIS THERAPEUTICS INC COM | 120,000 | 3,257,000 | 0.78% | ||
| 25 | iRhythm Technologies, Inc. | 115,182 | 3,455,000 | 0.83% | ||
| 26 | AQUINOX PHARMACEUTICALS INC | 225,000 | 3,715,000 | 0.89% | ||
| 27 | QIAGEN NV | 135,000 | 3,783,000 | 0.91% | ||
| 28 | ENTELLUS MED INC | 200,000 | 3,794,000 | 0.91% | ||
| 29 | SPARK THERAPEUTICS INCORPORATED | 80,000 | 3,992,000 | 0.96% | ||
| 30 | Wright Medical Group NV | 175,000 | 4,022,000 | 0.97% | ||
| 31 | FOAMIX PHARMACEUTICALS LTD | 365,000 | 4,052,000 | 0.98% | ||
| 32 | ENDO INTL PLC | 250,000 | 4,118,000 | 0.99% | ||
| 33 | BIOGEN INC | 15,000 | 4,254,000 | 1.02% | ||
| 34 | CURRENCYSHARES SWISS FRANC T | 46,400 | 4,349,000 | 1.05% | ||
| 35 | SAREPTA THERAPEUTICS INC | 200,000 | 5,486,000 | 1.32% | Call | |
| 36 | NANOSTRING TECHNOLOGIES INC | 250,000 | 5,575,000 | 1.34% | ||
| 37 | EPIZYME INC COM | 475,000 | 5,748,000 | 1.38% | ||
| 38 | PERRIGO CO PLC | 70,000 | 5,826,000 | 1.40% | ||
| 39 | AGIOS PHARMACEUTICALS INC | 140,000 | 5,842,000 | 1.41% | ||
| 40 | BRISTOL MYERS SQUIBB CO | 100,000 | 5,844,000 | 1.41% | ||
| 41 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 575,000 | 5,974,000 | 1.44% | ||
| 42 | PUMA BIOTECHNOLOGY | 200,000 | 6,140,000 | 1.48% | Call | |
| 43 | IMMUNOMEDICS INCORPORATED | 1,700,000 | 6,239,000 | 1.50% | ||
| 44 | BOSTON SCIENTIFIC CORP | 300,000 | 6,489,000 | 1.56% | Call | |
| 45 | NEVRO CORP COM | 90,000 | 6,539,000 | 1.57% | ||
| 46 | AERIE PHARMACEUTICALS INC COM | 175,000 | 6,624,000 | 1.59% | ||
| 47 | MALLINCKRODT PUB LTD CO | 135,000 | 6,726,000 | 1.62% | ||
| 48 | LION BIOTECHNOLOGIES INC COM | 975,000 | 6,776,000 | 1.63% | ||
| 49 | GLAUKOS CORP | 200,000 | 6,860,000 | 1.65% | ||
| 50 | BIOCRYST PHARMACEUTICALS | 1,150,000 | 7,280,000 | 1.75% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-17-000789, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
